IRD
Opus Genetics, Inc.
-0.11 (-2.02%)5.30USD542K成交股數441M市值–本益比(近四季)44.7股價營收比-73.8%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 755K-83% | 2.2M-50% | 3.1M-20% | 2.9M+159% | 4.4M+155% | 4.3M-64% | 3.9M+5% | 1.1M-36% | 1.7M | 11.9M | 3.7M | 1.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 11.2M | 10.6M | 6.4M | 6.0M | 8.0M | 7.0M | 9.0M | 6.1M | 4.7M | 3.5M | 4.7M | 5.6M |
| 銷售管理費用 | 6.0M | 5.9M | 5.0M | 5.8M | 6.3M | 7.3M | 2.9M | 3.4M | 4.7M | 2.1M | 4.3M | 2.3M |
| 營業利益 | −16.5M+66% | −14.4M-62% | −8.3M+4% | −8.9M+7% | −9.9M+29% | −38.0M-696% | −8.0M+49% | −8.3M+36% | −7.7M | 6.4M | −5.4M | −6.1M |
| 營業利益率 | -2,182.8% | -665.9% | -269.9% | -309.0% | -227.2% | -884.0% | -207.1% | -748.9% | -450.5% | 53.5% | -146.7% | -350.5% |
| 稅後淨利 | −8.1M-1% | −65.5M+87% | −17.5M+132% | −7.4M-4% | −8.2M+15% | −35.1M-732% | −7.5M+52% | −7.8M+34% | −7.1M | 5.6M | −5.0M | −5.8M |
| 淨利率 | -1,072.6% | -3,038.2% | -566.9% | -257.5% | -187.5% | -816.7% | -194.6% | -698.3% | -415.3% | 46.6% | -135.0% | -331.1% |
| 稀釋 EPS | -0.14-42% | -0.75-41% | -0.25-14% | -0.12-60% | -0.24-17% | -1.27-608% | -0.29+21% | -0.30+7% | -0.29 | 0.25 | -0.24 | -0.28 |
| 稀釋股數 | 111M | 86.9M | 70.6M | 63.4M | 33.9M | 26.7M | 26.1M | 25.8M | 24.5M | 22.4M | 21.0M | 20.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 88.8M | 60.0M | 30.8M | 32.4M | 41.8M | 30.3M | 36.6M | 41.4M | 47.2M | 42.4M | 40.0M | 39.0M |
| 應收帳款 | 1.0M | 1.7M | 2.9M | 3.4M | 3.1M | 3.6M | 1.9M | 1.4M | 1.9M | 10.1M | 135K | 2.8M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 93.0M | 66.8M | 36.1M | 38.7M | 48.2M | 36.9M | 40.4M | 44.8M | 51.8M | 54.2M | 43.5M | 45.4M |
| 有息負債 | 35.3M | 1.2M | 1.1M | 1.0M | – | 0.00 | – | – | – | – | – | – |
| 總負債 | 106M | 87.9M | 30.2M | 21.2M | 24.3M | 11.3M | 6.1M | 4.2M | 5.8M | 3.9M | 5.8M | 4.2M |
| 股東權益 | −13.0M | −45.8M | 6.0M | 17.5M | 5.1M | 6.7M | 34.3M | 40.6M | 46.1M | 50.3M | 37.7M | 41.3M |
| 負債比 | 114.0% | 131.6% | 83.5% | 54.8% | 50.3% | 30.6% | 15.1% | 9.4% | 11.2% | 7.2% | 13.3% | 9.1% |
| 淨現金(現金 − 有息負債) | 53.5M | 58.8M | 29.7M | 31.4M | – | 30.3M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.7M | – | – | −9.0M+57% | – | – | – | −5.7M | – | – | −3.6M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 14.2M | +29.1% | −49.6M | -349.3% | -0.80 | – |
| FY2024 | 11.0M | -42.3% | −57.5M | -523.4% | -2.15 | – |
| FY2023 | 19.0M | -52.2% | −10.0M | -52.4% | -0.46 | – |
| FY2022 | 39.9M | +6665.7% | 17.9M | 44.9% | 0.87 | – |
| FY2021 | 589K | – | −56.7M | -9,625.3% | -3.82 | – |
| FY2020 | 0.00 | -100.0% | −24.6M | –% | -5.28 | −6.8M |
| FY2019 | 3.0M | – | −6.2M | -205.6% | -2.17 | −3.6M |
| FY2018 | – | – | −14.4M | –% | -5.25 | – |